Medical Market Report

Global Non-steroidal Anti-inflammatory Drugs Market By Type (Aspirin, Ibuprofen, Naproxen, and Nabumetone), By Application (Back Pain Treatment, and Osteoarthritis Treatment), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 136984
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    The report on Non-steroidal Anti-inflammatory Drugs Market offers in-depth analysis of market trends, drivers, restraints, opportunities etc. Along with qualitative information, this report includes the quantitative analysis of various segments in terms of market share, growth, opportunity analysis, market value, etc. for the forecast years. The global non-steroidal anti-inflammatory drugs market is segmented on the basis of Type, Application, and geography.

    The Worldwide market for Non-steroidal Anti-inflammatory Drugs Market is expected to grow at a CAGR of roughly x.x% over the next nine years, and will reach US$ XX.X Mn in 2028, from US$ XX.X Mn in 2018, according to a new Market.us (Prudour Research) study.

    Non-steroidal Anti-inflammatory Drugs Market Scope:

    By type, the market is segmented into Aspirin, Ibuprofen, Naproxen, and Nabumetone. By Application, the market is divided into Back Pain Treatment, and Osteoarthritis Treatment.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Glaxo Smith Kline, Johnson & Johnson, Bayer, Novacap, Abbott, Pfizer, Pfizer, Perrigo Company, Kopran, Merck Sharp & Dohme, Sun Pharmaceutical Industries, and Reddy Pharmaceuticals.

    Key Market Segments

    Type

    Aspirin
    Ibuprofen
    Naproxen
    Nabumetone

    Application

    Back Pain Treatment
    Osteoarthritis Treatment

    Key Market Players included in the report:

    Glaxo Smith Kline
    Johnson & Johnson
    Bayer
    Novacap
    Abbott
    Pfizer
    Pfizer
    Perrigo Company
    Kopran
    Merck Sharp & Dohme
    Sun Pharmaceutical Industries
    Reddy Pharmaceuticals

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Non-steroidal Anti-inflammatory Drugs Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Non-steroidal Anti-inflammatory Drugs Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Non-steroidal Anti-inflammatory Drugs Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Non-steroidal Anti-inflammatory Drugs Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Non-steroidal Anti-inflammatory Drugs Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Non-steroidal Anti-inflammatory Drugs Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Non-steroidal Anti-inflammatory Drugs sub-markets, depending on key regions (various vital states).
    To analyze Non-steroidal Anti-inflammatory Drugs Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Non-steroidal Anti-inflammatory Drugs Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2014 to 2019, and also prediction to 2028.
    Primary worldwide Non-steroidal Anti-inflammatory Drugs Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Non-steroidal Anti-inflammatory Drugs Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players3. Global Non-steroidal Anti-inflammatory Drugs Market Overview
    

    3.1. Non-steroidal Anti-inflammatory Drugs Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges  3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy4. Global Non-steroidal Anti-inflammatory Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Non-steroidal Anti-inflammatory Drugs Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Aspirin
    

      4.4. Ibuprofen
    

      4.5. Naproxen
    

      4.6. Nabumetone5. Global Non-steroidal Anti-inflammatory Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Non-steroidal Anti-inflammatory Drugs Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Back Pain Treatment
    

      5.4. Osteoarthritis Treatment6. Global Non-steroidal Anti-inflammatory Drugs Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Non-steroidal Anti-inflammatory Drugs Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Non-steroidal Anti-inflammatory Drugs Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Non-steroidal Anti-inflammatory Drugs Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Non-steroidal Anti-inflammatory Drugs Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Non-steroidal Anti-inflammatory Drugs Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    
7. Global Non-steroidal Anti-inflammatory Drugs Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Glaxo Smith Kline
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments  7.4. Johnson & Johnson
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments  7.5. Bayer
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments  7.6. Novacap
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments  7.7. Abbott
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments  7.8. Pfizer
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments  7.9. Pfizer
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments  7.10. Perrigo Company
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments  7.11. Kopran
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments  7.12. Merck Sharp & Dohme
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments  7.13. Sun Pharmaceutical Industries
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments  7.14. Reddy Pharmaceuticals
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.